Occam Places Eva Jack as COO of Hotspot
HotSpot is a private biotech and an investment of Atlas Venture. The company recently raised $100M in a Series C financing and has a platform addressing a number of major disease states including oncology and rare diseases.
In late 2020, Occam recruited Eva Jack, previously CBO of Mersana Therapeutics, to be the COO in a role that would also encompass Business Development.
Recent Placements
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.